Dermatology Times

JUNE 9, 2024

Jonathan Silverberg, MD, PhD, MPH, presented his tips for effectively treating atopic dermatitis without worsening autoimmune comorbidities.

Dermatitis 92

Dermatitis 92

Dermatology Times

JUNE 10, 2024

David Rosmarin, MD, shares key points from phase 3 data of ruxolitinib for vitiligo, as well as highlights the potential for targeting the STAT pathway in upcoming atopic dermatitis therapeutics.

Dermatitis 85

Dermatitis 85

Dermatology Times

JUNE 10, 2024

Melinda Gooderham, MSc, MD, FRCPC, discusses potential new biologics for atopic dermatitis that target IL-22, IL-33, OX40, and more.

Dermatitis 74

Dermatitis 74

Dermatology Times

JUNE 1, 2024

Raj Chovatiya, MD, PhD, takes a deep dive in the challenges, solutions, and further research needed to treat seborrheic dermatitis.

Dermatitis 80

Dermatitis Treatments 80

Dermatology Times

MAY 30, 2024

Raj Chovatiya, MD, PhD, reviews the varying degrees of influence of skin barrier disruption, immune dysregulation, and Malassezia yeast in seborrheic dermatitis.

Dermatitis 74

Dermatitis 74

Dermatology Times

OCTOBER 27, 2024

At Fall Clinical 2024, Christopher Bunick, MD, PhD, discussed systemic therapy options and the importance of comprehensive treatment targets in managing atopic dermatitis, emphasizing AHEAD recommendations and LEVEL UP data.

Dermatitis 53

Dermatitis Treatments Therapy Management 53

Dermatology Times

AUGUST 27, 2024

The AHEAD recommendations focus on achieving disease control in atopic dermatitis by allowing patients to identify key symptoms and clinicians to select matching outcomes to guide therapy, aiming for a higher standard of care.

Dermatitis 45

Dermatitis Treatments Therapy 45

Dermatology Times

JUNE 11, 2024

Gil Yosipovitch, MD, addresses the severity of chronic itch and sleep disturbances in patients with atopic dermatitis.

Dermatitis 77

Dermatitis 77

Dermatology Times

APRIL 12, 2024

Dr Alexandra Golant discusses managing multiple conditions in a 17-year-old African American waitress, highlighting the complexities of treating moderate-to-severe atopic dermatitis alongside severe acne and oral contraceptives. She also addresses potential drug interactions, focusing on the safety of dupilumab in systemic treatment.

Dermatitis 85

Dermatitis Treatments Safety Management 85

Dermatology Times

NOVEMBER 14, 2024

Poster compared quality of life improvement for dupilumab vs lebrikizumab in atopic dermatitis.

Dermatitis 41

Dermatitis 41

Dermatology Times

MARCH 4, 2024

Raj Chovatiya, MD, PhD, gives a sneak peek of what to expect in atopic dermatitis education at the 2024 American Academy of Dermatology (AAD) Meeting in San Diego, California March 8-12. Since the last meeting, the AAD has released new guidelines to treat the condition.

Dermatitis 74

Dermatitis Education Dermatology 74

Dermatology Times

JUNE 11, 2024

Kristine Kucera, PA-C, MPAS, DHS, discusses the atopic dermatitis patient experience alongside one of her patients, Mickey Bryson.

Dermatitis 74

Dermatitis 74

Dermatology Times

JANUARY 11, 2024

Innovative practice pearls for both vitiligo and atopic dermatitis treatment were shared with nearly 200 clinicians to put into practice at the virtual Revolutionizing Vitiligo and Revolutionizing Atopic Dermatitis Conferences.

Dermatitis 74

Dermatitis Innovations Treatments 74

Dermatology Times

NOVEMBER 4, 2023

Test your knowledge on approved biologics in the management of moderate to severe atopic dermatitis and considerations for an 18-year-old man's case.

Dermatitis 78

Dermatitis Management 78

Dermatology Times

JULY 13, 2024

Lio discusses his SPD 2024 non-CME talk, new and exciting innovations in pediatric atopic dermatitis, and more.

Dermatitis 78

Dermatitis Innovations 78

Dermatology Times

JANUARY 9, 2024

Test your knowledge and explore a recent study on the relationship between alcohol consumption and skin diseases, including atopic dermatitis.

Dermatitis 74

Dermatitis 74

Dermatology Times

NOVEMBER 10, 2023

A new study presented at this year’s American College of Allergy, Asthma and Immunology Annual Scientific Meeting highlights the need for mental health support in patients with atopic dermatitis.

Dermatitis 78

Dermatitis 78

Dermatology Times

APRIL 18, 2024

Researchers noted that further examination and monitoring for headache disorders in patients with atopic dermatitis may be warranted.

Dermatitis 78

Dermatitis 78

First Derm

FEBRUARY 21, 2024

Eczema (Atopic Dermatitis) Eczema, also known as atopic dermatitis, is a common skin condition characterized by characterized by impaired skin barrier function, intense itching, recurrent eczematous lesions, and is often associated with other allergic conditions. [1] Contact dermatitis from metals, latex, chemicals.

Eczema 59

Eczema Dermatitis Management Medical 59

Dermatology Times

DECEMBER 11, 2023

A poster from the 2023 Revolutionizing Atopic Dermatitis Conference revealed a link between AD, impaired oral health, and oral dysbiosis.

Dermatitis 81

Dermatitis 81

Dermatology Times

JANUARY 16, 2024

The FDA has added efficacy and safety data for patients ages 12 years and older with uncontrolled moderate-to-severe atopic dermatitis with hand and/or foot involvement.

Dermatitis 74

Dermatitis Safety 74

Dermatology Times

DECEMBER 15, 2023

is the first FDA-approved drug for seborrheic dermatitis with a new mechanism of action in over 2 decades. Roflumilast foam 0.3% Christopher Bunick, MD, PhD; Shawn Kwatra, MD; and Peter Lio, MD, share expert insights.

Dermatitis 74

Dermatitis 74

Dermatology Times

NOVEMBER 12, 2023

What are some of the challenges and triumphs in using biologics for atopic dermatitis? Allen, RN, NP, shares insights at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting.

Dermatitis 87

Dermatitis 87

Dermatology Times

APRIL 12, 2024

Linda Stein-Gold, MD, and Michael Cameron, MD, FAAD, discuss the need for non-steroidal treatment options in atopic dermatitis management, driven by patient preferences.

Dermatitis 69

Dermatitis Treatments Irritation Management 69

Beautiful With Brains - Skincare

MARCH 27, 2024

So, naturally, you treat it like you would any other breakout and think it will […] The post Your Acne May Actually Be Perioral Dermatitis appeared first on Beautiful With Brains.

Dermatitis 52

Dermatitis Skincare 52

Dermatology Times

NOVEMBER 11, 2024

RAD will join MJH's multichannel model, enhancing its educational impact in atopic dermatitis, alopecia areata, vitiligo, and eczema.

Dermatitis 45

Dermatitis Eczema Dermatology Education 45

Dermatology Times

SEPTEMBER 6, 2023

As we approach National Eczema Week and National Eczema Month, take a look at the most influential atopic dermatitis research from the last decade.

Dermatitis 78

Dermatitis Eczema 78

Dermatology Times

MAY 7, 2024

A 5-expert panel delves into atopic dermatitis guidelines and recommendations and recent studies to make note of.

Dermatitis 88

Dermatitis Clinic Treatments 88

Dermatology Times

DECEMBER 11, 2023

Jennifer Etienne shared her experiences during the shared decision-making patient panel of the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.

Dermatitis 73

Dermatitis 73

Dermatology Times

OCTOBER 2, 2023

Check in throughout the month to learn more about the latest treatment pearls and research findings in DermIQ’s spotlight on atopic dermatitis.

Dermatitis 74

Dermatitis Treatments 74

Dermatology Times

FEBRUARY 23, 2024

Researchers have found Staphylococcus aureus may trigger itchiness in atopic dermatitis, opening the door to new treatment approaches in the future.

Dermatitis 53

Dermatitis Treatments 53

West Lake Dermatology

MARCH 25, 2024

Seborrheic Dermatitis (SD) is common skin condition known for its chronic and recurrent nature. Understanding seborrheic dermatitis is the first step towards managing it effectively. What Is Seborrheic Dermatitis? Who’s At Risk For Developing Seborrheic Dermatitis? SD can affect individuals of all ages and races.

Dermatitis 36

Dermatitis Treatments Management Eczema 36

Dermatology Times

JANUARY 22, 2024

Zoryve was approved for the treatment of seborrheic dermatitis in patients ages 9 years and older in December.

Dermatitis 78

Dermatitis Treatments 78

Dermatology Times

OCTOBER 1, 2023

October is Eczema Awareness Month and Dermatology Times is recognizing research to best serve patients with the most common type of eczema, atopic dermatitis.

Dermatitis 74

Dermatitis Eczema Dermatology 74

Dermatology Times

NOVEMBER 21, 2023

From the November cover: Raj Chovatiya, MD, PhD, and Lawrence Eichenfield, MD, shared their insights and key treatment pearls into atopic dermatitis management for adults and children.

Dermatitis 73

Dermatitis Management Treatments 73

Dermatology Times

OCTOBER 11, 2023

Dermatologist Diego Ruiz Dasilva, MD, FAAD, and a patient with atopic dermatitis discuss the patient journey from initial symptoms to diagnosis to treatment selection.

Dermatitis 74

Dermatitis Treatments 74

Dermatology Times

SEPTEMBER 30, 2023

Colleen Cotton, MD, does a deep dive on pediatric atopic dermatitis and explains the importance of timing and conversations with patients about different treatments.

Dermatitis 78

Dermatitis Treatments 78